Within-host dynamics of SARS-CoV-2 infection: A systematic review and meta-analysis
- PMID: 35907777
- PMCID: PMC9353427
- DOI: 10.1111/tbed.14673
Within-host dynamics of SARS-CoV-2 infection: A systematic review and meta-analysis
Abstract
Within-host model specified by viral dynamic parameters is a mainstream tool to understand SARS-CoV-2 replication cycle in infected patients. The parameter uncertainty further affects the output of the model, such as the efficacy of potential antiviral drugs. However, gathering empirical data on these parameters is challenging. Here, we aim to conduct a systematic review of viral dynamic parameters used in within-host models by calibrating the model to the viral load data measured from upper respiratory specimens. We searched the PubMed, Embase and Web of Science databases (between 1 December 2019 and 10 February 2022) for within-host modelling studies. We identified seven independent within-host models from the above nine studies, including Type I interferon, innate response, humoral immune response or cell-mediated immune response. From these models, we extracted and analyse seven widely used viral dynamic parameters including the viral load at the point of infection or symptom onset, the rate of viral particles infecting susceptible cells, the rate of infected cells releasing virus, the rate of virus particles cleared, the rate of infected cells cleared and the rate of cells in the eclipse phase can become productively infected. We identified seven independent within-host models from nine eligible studies. The viral load at symptom onset is 4.78 (95% CI:2.93, 6.62) log(copies/ml), and the viral load at the point of infection is -1.00 (95% CI:-1.94, -0.05) log(copies/ml). The rate of viral particles infecting susceptible cells and the rate of infected cells cleared have the pooled estimates as -6.96 (95% CI:-7.66, -6.25) log([copies/ml]-1 day-1 ) and 0.92 (95% CI:-0.09, 1.93) day-1 , respectively. We found that the rate of infected cells cleared was associated with the reported model in the meta-analysis by including the model type as a categorical variable (p < .01). Joint viral dynamic parameters estimates when parameterizing within-host models have been published for SARS-CoV-2. The reviewed viral dynamic parameters can be used in the same within-host model to understand SARS-CoV-2 replication cycle in infected patients and assess the impact of pharmaceutical interventions.
Keywords: COVID-19; SARS-CoV-2; review; viral dynamic parameters; within-host model.
© 2022 Wiley-VCH GmbH.
Similar articles
-
Multiple cohort study of hospitalized SARS-CoV-2 in-host infection dynamics: Parameter estimates, identifiability, sensitivity and the eclipse phase profile.J Theor Biol. 2023 May 7;564:111449. doi: 10.1016/j.jtbi.2023.111449. Epub 2023 Mar 7. J Theor Biol. 2023. PMID: 36894132 Free PMC article.
-
SARS-CoV-2 viral dynamic modeling to inform model selection and timing and efficacy of antiviral therapy.CPT Pharmacometrics Syst Pharmacol. 2023 Oct;12(10):1450-1460. doi: 10.1002/psp4.13022. Epub 2023 Aug 21. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37534815 Free PMC article.
-
A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response.J Theor Biol. 2022 Dec 21;555:111293. doi: 10.1016/j.jtbi.2022.111293. Epub 2022 Oct 5. J Theor Biol. 2022. PMID: 36208668 Free PMC article.
-
The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.Infect Genet Evol. 2021 Jul;91:104832. doi: 10.1016/j.meegid.2021.104832. Epub 2021 Apr 1. Infect Genet Evol. 2021. PMID: 33812037 Free PMC article.
-
Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies.J Cell Physiol. 2021 Apr;236(4):2364-2392. doi: 10.1002/jcp.30032. Epub 2020 Sep 9. J Cell Physiol. 2021. PMID: 32901936
Cited by
-
A mathematical model for the within-host (re)infection dynamics of SARS-CoV-2.Math Biosci. 2024 May;371:109178. doi: 10.1016/j.mbs.2024.109178. Epub 2024 Mar 13. Math Biosci. 2024. PMID: 38490360 Free PMC article.
-
Developing an appropriate evolutionary baseline model for the study of SARS-CoV-2 patient samples.PLoS Pathog. 2023 Apr 5;19(4):e1011265. doi: 10.1371/journal.ppat.1011265. eCollection 2023 Apr. PLoS Pathog. 2023. PMID: 37018331 Free PMC article. Review.
-
Intra- and Inter-host Transmission Dynamics of SARS-CoV-2 Through Viral Load Data Analysis.Cureus. 2025 Apr 24;17(4):e82955. doi: 10.7759/cureus.82955. eCollection 2025 Apr. Cureus. 2025. PMID: 40416259 Free PMC article.
References
REFERENCES
-
- Bai, Y., Shen, M., & Zhang, L. (2022). Antiviral efficacy of molnupiravir for COVID-19 treatment. Viruses, 14, https://doi.org/10.3390/v14040763
-
- Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., & Others. (2020). Remdesivir for the treatment of Covid-19-Preliminary report. The New England Journal of Medicine, 383, 1813-1836.
-
- Challenger, J., Foo, C. Y., Wu, Y., Yan, A. W. C., Marjaneh, M. M., Liew, F., Thwaites, R. S., Okell, L. C., & Cunnington, A. J. (2022). Modelling upper respiratory viral load dynamics of SARS-CoV-2. BMC Medicine, 20, 25.
-
- Czuppon, P., Debarre, F., Goncalves, A., Tenaillon, O., Perelson, A. S., Guedj, J., & Blanquart, F. (2021). Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLOS Computational Biolog, 17, e1008752.
-
- Davies, N. G., Barnard, R. C., Jarvis, C. I., & Kucharski, A. J. (2020). Estimated transmissibility and severity of novel SARS-CoV-2 variant of concern 202012/01 in England. medRxiv.
Publication types
MeSH terms
Substances
Grants and funding
- 2022YFE0112300/Key Program for International Science and Technology Cooperation Projects of China
- 72104208/National Natural Science Foundation of China
- 21200632/Health and Medical Research Fund, Food and Health Bureau, Government of the Hong Kong Special Administrative Region
- 20180101332JC/Natural Science Foundation of Jilin Provincial Science and Technology Department
- JJKH20210135KJ/Science and Technology Project of the Jilin Provincial Education Department
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous